Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
24.32
-0.37 (-1.50%)
Mar 5, 2026, 4:00 PM EST - Market closed
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 182 employees as of December 31, 2025. The number of employees increased by 1 or 0.55% compared to the previous year.
Employees
182
Change (1Y)
1
Growth (1Y)
0.55%
Revenue / Employee
$3,236,203
Profits / Employee
$1,177,615
Market Cap
2.97B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 503 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 224 |
| Liquidia | 170 |
| Edgewise Therapeutics | 146 |
CPRX News
- 7 days ago - Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance - GlobeNewsWire
- 9 days ago - Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference - GlobeNewsWire
- 14 days ago - Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs - Seeking Alpha
- 22 days ago - Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 7 weeks ago - Catalyst Pharmaceuticals, Inc. (CPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire